64
Views
0
CrossRef citations to date
0
Altmetric
Corrigendum

Profile of gantenerumab and its potential in the treatment of Alzheimer’s disease [Corrigendum]

Page 569 | Published online: 21 May 2014
This article refers to:
Profile of gantenerumab and its potential in the treatment of Alzheimer’s disease

Novakovic D, Feligioni M, Scaccianoce S, et al. Drug Des Devel Ther. 2013;7:1359–1364.

On page 1362, left hand column, last sentence under Functional studies:

The effects of gantenerumab on cognitive assessment in the Morris water maze test were inconclusive, as both wild-type and transgenic AD mice injected with vehicle displayed impairment of learning, which might be ascribed to stress conditions caused by weekly intracerebroventricular injections. Importantly, neurological or motor impairments were not detected even after 5 months of treatment.24

Should read as:

The effects of gantenerumab on cognitive assessment in the Morris water maze test were inconclusive, as both wild-type and transgenic AD mice injected with vehicle displayed impairment of learning, which might be ascribed to stress conditions caused by weekly intravenous injections. Importantly, neurological or motor impairments were not detected even after 5 months of treatment.24